35697-16-6 Usage
Description
cis-5,6,7,8-tetrahydronaphthalene-1,6,7-triol, also known as cis-5,6,7,8-Tetrahydro-1,6,7-naphthalenetriol, is an organic compound with a unique molecular structure characterized by a tetrahydronaphthalene ring and three hydroxyl groups. It is an important intermediate in the synthesis of various pharmaceutical compounds due to its versatile chemical properties.
Uses
Used in Pharmaceutical Industry:
cis-5,6,7,8-tetrahydronaphthalene-1,6,7-triol is used as an intermediate for the preparation of nondepressant β-adrenergic blocking agents. These agents are crucial in the treatment of various cardiovascular conditions, such as hypertension, angina, and arrhythmias. cis-5,6,7,8-tetrahydronaphthalene-1,6,7-triol's unique structure allows for the development of drugs with minimal side effects on the central nervous system, making it a valuable component in the synthesis of these medications.
Check Digit Verification of cas no
The CAS Registry Mumber 35697-16-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,6,9 and 7 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 35697-16:
(7*3)+(6*5)+(5*6)+(4*9)+(3*7)+(2*1)+(1*6)=146
146 % 10 = 6
So 35697-16-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O3/c11-8-3-1-2-6-4-9(12)10(13)5-7(6)8/h1-3,9-13H,4-5H2
35697-16-6Relevant articles and documents
ACYL GUANIDINE SODIUM/PROTON EXCHANGE INHIBITORS AND METHOD
-
Page/Page column 31-32, (2010/02/10)
Acyl guanidines are provided which are sodium/proton exchange (NHE) inhibitors which have the structure wherein n is 1 to 5; X is N or C-R5 wherein R5 is H, halo, alkenyl, alkynyl, alkoxy, alkyl, aryl or heteroaryl; and R1, R2, R3 and R4 are as defined herein, and where X is N, R1 is preferably aryl or heteroaryl, and are useful as antianginal and cardioprotective agents. In addition, a method is provided for preventing or treating angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia employing the above acyl guanidines.
Esters of tetrahydronaphthyloxy-aminopropanols
-
, (2008/06/13)
Compounds having the formula STR1 wherein R1 is lower alkyl; R3, R4, R5, R6, and R7 are the same or different and are hydrogen or lower alkyl; R8, R9, and R10 are the same or different and are hydrogen, lower alkyl, lower alkoxy or cycloalkyl; and R11 is acyl; are useful in the treatment of coronary diseases.